Article Details
Retrieved on: 2025-04-12 10:10:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here